The opioid crisis is an international public health concern. Treatments for opioid use
disorder centre largely on the management of opioid withdrawal, an aversive collection of …

Importance Fentanyl has exacerbated the opioid use disorder (OUD) and opioid overdose
epidemic. Data on the effectiveness of medications for OUD among patients using fentanyl …

Importance Buprenorphine treatment of opioid use disorder (OUD) is safe and effective, but
opioid withdrawal during treatment initiation is associated with poor retention in care. As …

Importance Local-level data are needed to understand whether the relaxation of X-waiver
training requirements for prescribing buprenorphine in April 2021 translated to increased …

Abstract Background and Aims Buprenorphine is an evidence‐based treatment for opioid
use disorder, and the risk of precipitated withdrawal contributes to its underuse. The goal of …

Background Buprenorphine is an effective treatment for opioid use disorder (OUD);
however, buprenorphine initiation can be complicated by withdrawal symptoms including …

Background Federal regulations restrict methadone for opioid use disorder (OUD) treatment
to licensed opioid treatment programs (OTPs). However, providers in other settings can …

The “Things We Do for No Reason” series reviews practices, which have become common
parts of hospital care, may provide little value to our patients. Practices reviewed in the …

Purpose To demonstrate the challenges with current diagnosis and treatment strategies for
precipitated opioid withdrawal secondary to naloxone the emergency department (ED) …

Importance The US is experiencing a protracted drug overdose crisis primarily associated
with exposure to illicitly manufactured fentanyl (IMF), methamphetamine, and cocaine …